| Vote Recommendation | Economic Freedom | Property Rights | Personal Responsibility | Limited Government | Individual Liberty |
|---|---|---|---|---|---|
| Neutral | Neutral | Neutral | Neutral | Neutral | Neutral |
Relating to abortion complication reporting and the regulation of drug-induced abortion procedures, providers, and facilities; creating a criminal offense.
No significant fiscal implication to the State is anticipated.
SB 394 adds "adverse event" to the meaning of any harmful event or adverse outcome with respect to a patient related to an abortion performed or induced on the patient. These events must be reported by a physician who performs or induces at an abortion facility, diagnoses or treats a complication from an abortion performed or induced by another physician or a healthcare facility. These events now include blood clots, failure to actually terminate the pregnancy, pelvic inflammatory disease, endometritis, missed ectopic pregnancy, cardiac arrest, respiratory arrest, renal failure, metabolic disorder, embolism, coma, placenta previa in subsequent pregnancies, preterm delivery in subsequent pregnancies, fluid accumulation in the abdomen, hemolytic reaction from ABO-incompatible blood or products, adverse reactions to anesthesia or other drugs, or any other adverse event from MedWatch Reporting System.
SB 394 restricts any person from knowingly providing an abortion-inducing drug to a pregnant woman for the purpose of inducing an abortion unless that person is a physician and the provision of the abortion inducing drug satisfies the protocol authorized. A manufacturer, supplier, physician, or any other person may not provide any abortion inducing drug by courier, delivery, or mail service.
SB 394 requires the physician to examine the pregnant woman in person, independently verify the pregnancy, document the gestational age to determine if the ectopic pregnancy exists, determine the pregnant woman's blood type, document whether the pregnant woman received treatment for Rh negativity, and ensure the physician does not provide an abortion-inducing drug for a pregnancy that is more than 49 days of gestational age.
The physician who provides the abortion-inducing drug must schedule a follow up visit not later than the 14th day after the earliest date on which the abortion is performed or induced or the drug is administered or used. During this visit the physician must confirm the pregnancy was terminated and assess any continued blood loss.
Texas action views abortion as a social issue and therefore is neutral on SB 394.